Prediction of the response of colorectal cancer to systemic therapy.
about
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancerPrognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancerEfficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancerSTRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer.Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.Modern management of colorectal cancer--a pathologist's view.PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin.Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 yearsInsulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model.Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in Chinese cancer patients.PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients.Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells.Identification of oligopeptide binding to colon cancer cells separated from patients using laser capture microdissectionHMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
P2860
Q24651163-AD9DD0CC-029B-4889-9CBA-DC74F8CAD222Q28261456-56D4E785-E87A-4BF5-A473-D19447B7B0FAQ33354817-67419401-78A6-48E3-8AD1-7916F745E1ABQ34928876-CF6A3A21-1FB5-4A7B-B938-E0A259BDB144Q35000906-FDC43A5B-0876-4101-B2A1-C31504460C9CQ35111158-DD93A9B1-DC32-4343-876C-6886AB3D36D9Q35173768-6D628714-A9D9-4737-87A3-1D5B0994E81BQ35731144-CD1871ED-CCFA-49B5-8BC1-5E6150CD1827Q36097117-522BF0FB-EBD7-41FD-8146-76B594169A97Q36212999-E900D8A2-12C9-475D-8B67-2B53C8C01437Q36481670-CAB636BC-7655-4EDB-9C21-7AF827EE6CB4Q36487139-F5AC3239-3F76-49E8-88BA-4266E8FEC8EDQ36613531-920141CC-9A63-41B3-8BF1-3AB57911CF3CQ37328335-BB7EB339-82D4-4580-B057-889E3154E40FQ37631539-2D0E4C3C-E101-4C47-8547-C5C93123AC60Q38042875-89AF1A86-45DE-4963-85AE-4F58B9EC7D39Q43054639-214906C6-2340-4235-9D44-04E9D52F5CB2Q46614987-4D022157-6C56-43F5-87FE-1E32A49EDF3AQ49996562-CEB4D982-9430-48B8-A93A-EE2C02373ED9Q50976501-354D6E08-16DA-43C7-99CA-F9065286433FQ56893974-FB76389C-6614-4B92-8A37-F1CB25040786Q58695345-2ADE8570-581B-424D-A896-1628B3610673
P2860
Prediction of the response of colorectal cancer to systemic therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prediction of the response of colorectal cancer to systemic therapy.
@ast
Prediction of the response of colorectal cancer to systemic therapy.
@en
Prediction of the response of colorectal cancer to systemic therapy.
@en-gb
Prediction of the response of colorectal cancer to systemic therapy.
@nl
type
label
Prediction of the response of colorectal cancer to systemic therapy.
@ast
Prediction of the response of colorectal cancer to systemic therapy.
@en
Prediction of the response of colorectal cancer to systemic therapy.
@en-gb
Prediction of the response of colorectal cancer to systemic therapy.
@nl
prefLabel
Prediction of the response of colorectal cancer to systemic therapy.
@ast
Prediction of the response of colorectal cancer to systemic therapy.
@en
Prediction of the response of colorectal cancer to systemic therapy.
@en-gb
Prediction of the response of colorectal cancer to systemic therapy.
@nl
P1433
P1476
Prediction of the response of colorectal cancer to systemic therapy.
@en
P2093
Matthew T Seymour
Phil Quirke
P356
10.1016/S1470-2045(02)00648-4
P577
2002-02-01T00:00:00Z